Pulmonary Hypertension Caused by Interstitial Lung Disease: A New iNK(T)ling into Disease Pathobiology

Am J Respir Crit Care Med. 2022 Oct 15;206(8):930-932. doi: 10.1164/rccm.202206-1186ED.

Authors

Kadija Hersi^{1

2

3}, Jason M Elinoff¹

Affiliations

¹ Pulmonary Vascular Biology Section of the Critical Care Medicine Department National Institutes of Health Clinical Center Bethesda, Maryland.
² Division of Pulmonary and Critical Care Medicine University of Maryland School of Medicine Baltimore, Maryland.
³ National Heart, Lung and Blood Institute National Institutes of Health Bethesda, Maryland.

No abstract available

Publication types

Editorial
Comment

MeSH terms

Chemokine CXCL9
Humans
Hypertension, Pulmonary* / etiology
Hypertension, Pulmonary* / physiopathology
Ink
Lung Diseases, Interstitial* / complications
Lung Diseases, Interstitial* / diagnostic imaging
Pulmonary Fibrosis* / etiology
STAT1 Transcription Factor

Substances

CXCL9 protein, human
Chemokine CXCL9
STAT1 Transcription Factor
STAT1 protein, human